骨髓移植联合肾移植、亲属肾移植、尸体肾移植疗效的探讨  

Research of Kidney-bone Marrow Transplantation Living-related Renal Transplantation and Cadaver Donor Renal Transplantation

作　　者：秦奋[1] 王跃[2] 王志余 葛永超[3] 

机构地区：[1]郑州大学一附院泌尿外科,郑州市450000 [2]郑州大学一附院肾移植科,郑州市450000 [3]郑州第三人民医院泌尿外科,郑州市450000

出　　处：《医药论坛杂志》2010年第18期29-31,共3页Journal of Medical Forum

摘　　要：目的评价骨髓移植联合肾移植、亲属活体肾移植、尸体肾移植的疗效。方法对比三类肾移植各48例术后三个月内排斥反应的发生率。结果尸体肾移植联合骨髓移植较之单一尸体肾移植的急性排斥反应发生率显著降低,与亲属供肾肾移植相比急性排斥反应发生率已无明显差别。结论肾移植联合骨髓移植能通过增加混合嵌合体形成,从而诱导受体免疫耐受,可以减少排斥反应的发生,延长移植肾存活时间。Objective To estimate the curative effect of kidney - bone marrow transplantation,living -related renal transplantation,cadaver donor renal transplantation. Methods To compare the acute rejection rates of the three kinds of renal transplantations within three months after operation, every kind of transplantation group including 48 cases. Results The acute rejection rates of kidney - bone marrow transplantation are significantly lower than cadaver donor renal transplantation, the acute rejection rates are nearly equal between kidney - bone marrow transplantation and living - related renal transplantation. Conclusion Kidney- bone marrow transplantation can enhance the production of mixed chimeras, induce specific immune tolerance, decrease the incidence of acute rejection, extend survival time of renal allograft.

关 键 词：骨髓移植 肾移植 亲属活体肾移植 嵌合体 

分 类 号：R692[医药卫生—泌尿科学]